These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

640 related items for PubMed ID: 25726020

  • 21. Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.
    Taenaka R, Shimokawa S, Katayama A, Nagao T, Obara T, Nishimura N, Tsujimoto A, Kohno K, Aoki K, Ogawa R.
    J Med Case Rep; 2022 Aug 18; 16(1):311. PubMed ID: 35978379
    [Abstract] [Full Text] [Related]

  • 22. [Crow-Fukase (POEMS) syndrome: pathophysiology and treatments].
    Kuwabara S.
    Nihon Rinsho; 2013 May 18; 71(5):865-9. PubMed ID: 23777096
    [Abstract] [Full Text] [Related]

  • 23. [POEMS syndrome revealed by a scleroderma-like skin thickening].
    Toussaint P, Sibaud V, Labbe L, Geniaux M.
    Ann Dermatol Venereol; 2000 Jan 18; 127(1):73-6. PubMed ID: 10717569
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Marked recovery of severe renal lesions in POEMS syndrome with high-dose melphalan therapy supported by autologous blood stem cell transplantation.
    Sanada S, Ookawara S, Karube H, Shindo T, Goto T, Nakamichi T, Saito M, Matsubara M, Suzuki M.
    Am J Kidney Dis; 2006 Apr 18; 47(4):672-9. PubMed ID: 16564945
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome.
    Kulkarni GB, Mahadevan A, Taly AB, Yasha TC, Seshagiri KS, Nalini A, Satishchandra P, Veerendrakumar M, Shankar SK.
    J Clin Neurosci; 2011 Mar 18; 18(3):356-60. PubMed ID: 21256753
    [Abstract] [Full Text] [Related]

  • 30. [POEMS syndrome: Diagnosis, stratification, treatments].
    Talbot A, Jaccard A, Arnulf B.
    Rev Med Interne; 2021 May 18; 42(5):320-329. PubMed ID: 33678446
    [Abstract] [Full Text] [Related]

  • 31. [Efficacy of autologous peripheral blood stem cell transplantation (auto-PBSCT) on the neuropathic manifestations in POEMS syndrome].
    Gronier S, Delmont E, Legros L, Launay M, Jeandel PY, Fuzibet JG, Desnuelle C.
    Rev Neurol (Paris); 2014 Jan 18; 170(1):37-45. PubMed ID: 24411685
    [Abstract] [Full Text] [Related]

  • 32. New advances in the diagnosis and treatment of POEMS syndrome.
    Li J, Zhou DB.
    Br J Haematol; 2013 May 18; 161(3):303-15. PubMed ID: 23398538
    [Abstract] [Full Text] [Related]

  • 33. Successful treatment of a patient with POEMS syndrome by tandem high-dose chemotherapy with autologous CD34+ purged stem cell rescue.
    Kojima H, Katsuoka Y, Katsura Y, Suzuki S, Suzukawa K, Hasegawa Y, Nagasawa T.
    Int J Hematol; 2006 Aug 18; 84(2):182-5. PubMed ID: 16926143
    [Abstract] [Full Text] [Related]

  • 34. [Treatment strategy for POEMS syndrome].
    Kawamura N, Kira J.
    Brain Nerve; 2008 Jun 18; 60(6):621-6. PubMed ID: 18567357
    [Abstract] [Full Text] [Related]

  • 35. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
    Imai N, Taguchi J, Yagi N, Konishi T, Serizawa M, Kobari M.
    Neuromuscul Disord; 2009 May 18; 19(5):363-5. PubMed ID: 19269178
    [Abstract] [Full Text] [Related]

  • 36. Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
    Ishii Y, Yamazaki E, Ishiyama Y, Yamamoto E, Hattori Y, Hagihara M, Tomita N, Ishigatsubo Y.
    Int J Hematol; 2013 Dec 18; 98(6):723-8. PubMed ID: 24166587
    [Abstract] [Full Text] [Related]

  • 37. Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.
    Kuwabara S, Dispenzieri A, Arimura K, Misawa S, Nakaseko C.
    Cochrane Database Syst Rev; 2012 Jun 13; 2012(6):CD006828. PubMed ID: 22696361
    [Abstract] [Full Text] [Related]

  • 38. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes).
    Liang C, Gonzalez M, Patel R, Meehan S, Kamino H, Franks AG.
    Dermatol Online J; 2009 Aug 15; 15(8):9. PubMed ID: 19891917
    [Abstract] [Full Text] [Related]

  • 39. POEMS Syndrome: an Enigma.
    Warsame R, Yanamandra U, Kapoor P.
    Curr Hematol Malig Rep; 2017 Apr 15; 12(2):85-95. PubMed ID: 28299525
    [Abstract] [Full Text] [Related]

  • 40. POEMS Syndrome: Therapeutic Options.
    Jaccard A.
    Hematol Oncol Clin North Am; 2018 Feb 15; 32(1):141-151. PubMed ID: 29157615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.